These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38462792)

  • 1. Volatile anaesthetics and net zero: a quantitative approach for spending money effectively.
    Kalmar AF; Mulier H; Rex S
    Anaesthesia; 2024 Jun; 79(6):665-666. PubMed ID: 38462792
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring the cost of inhaled anaesthetics.
    Zych Z
    Br J Anaesth; 2002 Mar; 88(3):454; author reply 454. PubMed ID: 11990286
    [No Abstract]   [Full Text] [Related]  

  • 3. [Economic aspects of modern inhalation anesthetics with sevoflurane as an example].
    Bach A; Böhrer H; Schmidt H; Motsch J; Martin E
    Anaesthesist; 1997 Jan; 46(1):21-8. PubMed ID: 9082863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. $1.8 Million and counting: how volatile agent education has decreased our spending $1000 per day.
    Miller SA; Aschenbrenner CA; Traunero JR; Bauman LA; Lobell SS; Kelly JS; Reynolds JE
    J Clin Anesth; 2016 Dec; 35():253-258. PubMed ID: 27871537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of chirality of the fluorinated volatile inhalation anaesthetics on their clinical applications.
    Aboul-Enein HY; Bojarski J; Szymura-Oleksiak J
    Biomed Chromatogr; 2000 Jun; 14(4):213-8. PubMed ID: 10861731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of volatile anaesthetic agents.
    Daniel M
    Br J Anaesth; 1996 Sep; 77(3):437. PubMed ID: 8949832
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-flow anaesthesia: the sensible and judicious use of inhalation anaesthetics.
    Baum JA
    Acta Anaesthesiol Scand Suppl; 1997; 111():264-7. PubMed ID: 9421039
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].
    Kreuer S; Bruhn J; Wilhelm W; Bouillon T
    Anaesthesist; 2007 Jun; 56(6):538-56. PubMed ID: 17530207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volatile anaesthetics reduce neutrophil inflammatory response by interfering with CXC receptor-2 signalling.
    Müller-Edenborn B; Frick R; Piegeler T; Schläpfer M; Roth-Z'graggen B; Schlicker A; Beck-Schimmer B
    Br J Anaesth; 2015 Jan; 114(1):143-9. PubMed ID: 24989774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of volatile agents.
    Barker I
    Br J Anaesth; 1996 May; 76(5):749. PubMed ID: 8688286
    [No Abstract]   [Full Text] [Related]  

  • 11. PONV: a problem of inhalational anaesthesia?
    Apfel CC; Stoecklein K; Lipfert P
    Best Pract Res Clin Anaesthesiol; 2005 Sep; 19(3):485-500. PubMed ID: 16013696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns in volatile anaesthetic agent consumption over seven years in Victorian public hospitals.
    Weinberg L; Tay S; Aykanat V; Segal R; Tan CO; Peyton P; McNicol L; Story DA
    Anaesth Intensive Care; 2014 Sep; 42(5):579-83. PubMed ID: 25233170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile anaesthetics added to cardiopulmonary bypass are associated with reduced cardiac troponin.
    Bignami E; Guarnieri M; Pieri M; De Simone F; Rodriguez A; Cassarà L; Lembo R; Landoni G; Zangrillo A
    Perfusion; 2017 Oct; 32(7):547-553. PubMed ID: 28395591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proper use of CONTRAfluran™ for optimal desorption and reuse of volatile anaesthetics. Comment on Br J Anaesth 2022; 129: e79-81.
    Kalmar AF; Verdonck P; Saxena S; Mulier J
    Br J Anaesth; 2023 Sep; 131(3):e71-e72. PubMed ID: 37442725
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac troponins and volatile anaesthetics in coronary artery bypass graft surgery: A systematic review, meta-analysis and trial sequential analysis.
    Straarup TS; Hausenloy DJ; Rolighed Larsen JK
    Eur J Anaesthesiol; 2016 Jun; 33(6):396-407. PubMed ID: 26901389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomic viewpoints on volatile anaesthesia--"much ado about nothing?".
    Rapeport D; Harper S; Flisberg P
    Anaesth Intensive Care; 2005 Feb; 33(1):144-5. PubMed ID: 15957709
    [No Abstract]   [Full Text] [Related]  

  • 17. Volatile capture and net zero: spending money effectively.
    Leslie D; Silverman B
    Anaesthesia; 2023 Dec; 78(12):1521-1522. PubMed ID: 37527543
    [No Abstract]   [Full Text] [Related]  

  • 18. Occupational exposure to volatile anaesthetics: a systematic review.
    Molina Aragonés JM; Ayora Ayora A; Barbara Ribalta A; Gascó parici A; Medina Lavela JA; Sol Vidiella J; Sol López MH
    Occup Med (Lond); 2016 Apr; 66(3):202-7. PubMed ID: 26590956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile anaesthetics and positive pressure ventilation reduce left atrial performance: a transthoracic echocardiographic study in young healthy adults.
    Freiermuth D; Skarvan K; Filipovic M; Seeberger MD; Bolliger D
    Br J Anaesth; 2014 Jun; 112(6):1032-41. PubMed ID: 24561644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the costs of inhaled anaesthetics.
    Lockwood GG; White DC
    Br J Anaesth; 2001 Oct; 87(4):559-63. PubMed ID: 11878724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.